• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnaptysBio
    Picture of AnaptysBio logo

    ANABV — AnaptysBio News Story

    $43.800.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapHigh Flyer
    • Market Cap
      $1.94bn
    • Enterprise Value
      $1.91bn
    • Revenue
      $234.60m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANABV Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANABV Dividends
    All News

    NASDAQ RESUMED AT 11:34 AM

    Picture of AnaptysBio logoAnaptysBio
    06/04/2026 16:34
    NASDAQ RESUMED  ANABV.O  AT 11:34 AM
    

    Recent news on AnaptysBio

    See all news
    • U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

      15/05/2026 08:16
    • AnaptysBio's Q1 collaboration revenue falls, net loss widens

      12/05/2026 21:26
    • Brief: AnaptysBio Q1 Net Income USD -52.884 Million

      12/05/2026 21:15
    • Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors

      11/05/2026 14:28
    • Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged

      27/04/2026 07:13

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.